BioStack Raises $9.5 Million for Medical AI Data Network
Oct 22, 2026
Funding
ABK Biomedical Raises $35 Million in Series D Funding Led by J.P. Morgan Life Sciences
Nov 12, 2025
ABK Biomedical has secured $35 million in an oversubscribed Series D funding round led by J.P. Morgan Life Sciences Private Capital, with participation from existing investors. The funds will support clinical operations, commercialization of Eye90 microspheres, and expansion of manufacturing capabilities.
ABK Biomedical has raised $35 million in an oversubscribed Series D financing round led by new investor J.P. Morgan Life Sciences Private Capital, announced in a press release. Existing investors including F-Prime, Santé Ventures, Eight Roads Ventures, and an undisclosed medical device company also participated.
The funds will support the company’s ongoing clinical operations, preparation for the commercialization of its Eye90 microspheres, and further product development. Additional capital will be used to expand manufacturing and supply chain capabilities to meet future demand.
Eye90 microspheres, which have received FDA Breakthrough Device Designation, are currently being evaluated in the Route90 FDA IDE pivotal trial. The company aims to use the proceeds to advance the trial and position the product for market readiness.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareMore from Funding
Nov 13 Polar DC adds Palistar financing as 2026 commitments pass EUR 1 billion Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 MISTT raises £5 million to build a space-and-time data layer for AI and autonomous systems Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 12 Inveniam acquires Docugami, the document AI startup of XML pioneer Jean PaoliFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Formation Bio Forms $600 Million Drug Development Fund
Oct 28, 2026
Funding
Mosaic Raises $47M for Blood Vessel Surgery Robots
Nov 11, 2026
Funding
Araceli Biosciences Adds Investor to $4.5 Million Round
Nov 12, 2026
Funding
Kardi AI Raises €5.3 Million for Heart Monitoring Expansion
Nov 11, 2026
Funding
Laza Medical raises up to $160 million for cardiac imaging system
Nov 04, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.